Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior?

Ozge Bayrak, Nazlı Mert, Yasemin Basbinar, Serdar Bayrak

Open source

DOI: 10.1007/s12672-025-02403-8
Published: 2025-11-21
Container: Discover Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12672-025-02403-8,
  title = {Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior?},
  author = {Ozge Bayrak and Nazlı Mert and Yasemin Basbinar and Serdar Bayrak},
  year = {2025},
  journal = {Discover Oncology},
  doi = {10.1007/s12672-025-02403-8},
  url = {https://doi.org/10.1007/s12672-025-02403-8}
}

RIS

TY  - JOUR
TI  - Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior?
AU  - Ozge Bayrak
AU  - Nazlı Mert
AU  - Yasemin Basbinar
AU  - Serdar Bayrak
PY  - 2025
JO  - Discover Oncology
DO  - 10.1007/s12672-025-02403-8
UR  - https://doi.org/10.1007/s12672-025-02403-8
ER  -

APA

Bayrak, O., Mert, N., Basbinar, Y., & Bayrak, S. (2025). Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior?. Discover Oncology. https://doi.org/10.1007/s12672-025-02403-8

Source records

crossref · retrieved 2026-09-26T11:28:54.927Z